McGirt Matthew J, Chaichana Kaisorn L, Atiba April, Attenello Frank, Yao Kevin C, Jallo George I
Department of Neurosurgery, Johns Hopkins School of Medicine, Baltimore, Maryland 21218, USA.
J Neurosurg Pediatr. 2008 Jan;1(1):63-7. doi: 10.3171/PED-08/01/063.
With modern surgical advances, radical resection of pediatric intramedullary spinal cord tumors (IMSCTs) can be expected to preserve long-term neurological function. Nevertheless, postoperative neurological decline is not uncommon after surgery, and many patients continue to experience long-term dysesthetic symptoms. Preoperative predictors of postoperative neurological decline and sensory syndromes have not been investigated and may serve as a guide for surgical risk stratification.
Neurological function (as determined using the modified McCormick Scale [mMS]) preoperatively, postoperatively, and 3 months after surgery was retrospectively recorded from patient charts in 164 consecutive patients undergoing resection of IMSCTs. A median 4 years (interquartile range [IQR] 1-8 years) after surgery, long-term motor and sensory symptoms were assessed by telephone interviews and corroborated by subsequent medical visits in 120 available patients. This long-term assessment was retrospectively reviewed for the purposes of this study. The authors reviewed this series to assess long-term motor, sensory, and urinary outcomes and to determine independent risk factors of postoperative neurological decline and long-term sensory dysfunction.
Patients were 8.6 +/- 5.7 years old and presented with a median mMS of 2 (IQR 2-4). Three months after surgery, 38 patients (23%) continued to experience decreased neurological function (1 mMS point) incurred perioperatively. Increasing age (p = 0.028), unilateral symptoms (p = 0.046), and urinary dysfunction at presentation (p = 0.004) independently predicted persistent 3-month perioperative decline. At long-term follow-up (median 4 years), 39 (33%) exhibited improvements in their mMS scores, 13 (30%) had improvement in their urinary dysfunction, and 27 (30%) had resolution of their dysesthesias. Seventy-eight patients (65%) experienced long-term dysesthetic symptoms. Increasing age (p = 0.024), preoperative symptom duration > 12 months (p = 0.027), and worsened postoperative mMS score at hospital discharge (p = 0.013) independently increased the risk of long-term dysesthesias.
In the authors' experience, nearly one third of patients may experience improvement in motor, sensory, and urinary dysfunction years after IMSCT resection, whereas the majority will continue to experience long-term dysesthetic symptoms. Improvement in motor deficits preceded improvement in sensory syndromes, and urinary dysfunction typically resolved much longer after surgery. The risk of persistent perioperative motor decline was increased with older age, unilateral symptoms, preoperative urinary symptoms, and less severe preoperative neurological deficit. The risk of long-term dysesthesias was increased with older age, increased duration of symptoms prior to resection, and greater postoperative neurological deficit.
随着现代外科技术的进步,小儿脊髓髓内肿瘤(IMSCTs)的根治性切除有望保留长期神经功能。然而,术后神经功能下降在手术后并不少见,许多患者仍长期存在感觉异常症状。术后神经功能下降和感觉综合征的术前预测因素尚未得到研究,可能有助于手术风险分层。
回顾性记录了164例连续接受IMSCTs切除手术患者的病历,记录术前、术后及术后3个月的神经功能(采用改良麦考密克量表[mMS]测定)。术后中位4年(四分位间距[IQR]1 - 8年),通过电话访谈对120例可联系到的患者评估其长期运动和感觉症状,并通过随后的医疗就诊进行核实。为本研究目的,对该长期评估进行回顾性分析。作者回顾该系列病例以评估长期运动、感觉和泌尿功能结局,并确定术后神经功能下降和长期感觉功能障碍的独立危险因素。
患者年龄为8.6±5.7岁,mMS中位数为2(IQR 2 - 4)。术后3个月,38例患者(23%)仍存在围手术期出现的神经功能下降(mMS降低1分)。年龄增加(p = 0.028)、单侧症状(p = 0.046)和术前存在泌尿功能障碍(p = 0.004)是围手术期持续3个月神经功能下降的独立预测因素。在长期随访(中位4年)时,39例(33%)患者的mMS评分有所改善,13例(30%)患者的泌尿功能障碍有所改善,27例(30%)患者的感觉异常症状消失。78例患者(65%)存在长期感觉异常症状。年龄增加(p = 0.024)、术前症状持续时间>12个月(p = 0.027)和出院时术后mMS评分恶化(p = 0.013)是长期感觉异常风险增加的独立因素。
根据作者的经验,近三分之一的患者在IMSCTs切除术后数年,其运动、感觉和泌尿功能障碍可能会有所改善,而大多数患者仍将长期存在感觉异常症状。运动功能障碍的改善先于感觉综合征的改善,泌尿功能障碍通常在术后更长时间才得以解决。围手术期运动功能持续下降的风险随年龄增大、单侧症状、术前泌尿症状以及术前神经功能缺损较轻而增加。长期感觉异常的风险随年龄增大、切除术前症状持续时间延长以及术后神经功能缺损加重而增加。